Altumomab
Altumomab is a anti-huamn monoclonal antibody targeting CEACAM5/CEA/CD66e.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 156586-92-4
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Radionuclide-Drug Conjugates (RDCs) Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Isotype
Mouse IgG1 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
RDC Antibody |
In Vitro
Altumomab can be labeled with indium-111and be used to image white blood cells for in infectin[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Target
CEACAM5/CEA/CD66e
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Product Image
Anwendung
ELISA, FACS, Functional assay
Chemical Information
-
CAS. Nr. 156586-92-4
-
SMILES
[Altumomab]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)